Drug Safety

An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease. Read More

Prospective mothers taking a new class of cholesterol-lowering drugs might incur higher risk of spina bifida in their future children, according to a study published in the journal Drug Safety by researchers at Vanderbilt University Medical Center. Read More

A Vanderbilt University study published today in the Journal of Clinical Psychiatry may help patients prescribed higher doses of certain antidepressants feel better about attributed cardiac risks. Read More

Vanderbilt University Medical Center is among a handful of organizations engaged to provide expertise and data to the Sentinel System, a U.S. Food and Drug Administration program designed to monitor the safety of drugs and medical devices that have reached market. Sentinel uses electronic health records and health care billing… Read More

The Monroe Carell Jr. Children’s Hospital at Vanderbilt will begin using a new state-of-the-art automated robotic system in June to prepare intravenous and single-use syringe medications for inpatients, making it the first children’s hospital in Tennessee to implement the technology. Read More

William Cooper, M.D., MPH, Cornelius Vanderbilt Professor of Pediatrics and Health Policy, testified Tuesday before the U.S. Senate Health, Education, Labor and Pensions (HELP) committee regarding psychotropic medications and treatments for Attention Deficit Hyperactivity Disorder (ADHD). Read More

As more and better treatments are developed for heart disease, it is becoming more difficult to safely manage care as patients return home from the hospital. A new study led by Vanderbilt researchers highlights growing concern that the period after hospital discharge is a risky time, especially for cardiac patients. Read More